Koers Sunshine Heart Inc Nasdaq
Aandelen
US86782U1060
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 10,16 mln. 9,43 mln. | Omzet 2025 * | 11,78 mln. 10,95 mln. | Marktkapitalisatie | 2,6 mln. 2,42 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -19 mln. -17,65 mln. | Nettowinst (verlies) 2025 * | -16 mln. -14,86 mln. | EV/omzet 2024 * | 0,26 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,22 x |
K/w-verhouding 2024 * |
-0,1
x | K/w-verhouding 2025 * |
-0,35
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,97% |
Recentste transcriptie over Sunshine Heart Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nestor Jaramillo
CEO | Chief Executive Officer | 66 | 07-05-19 |
Robert Scott
DFI | Director of Finance/CFO | 44 | 01-01-13 |
John Erb
CHM | Chairman | 75 | 01-09-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Erb
CHM | Chairman | 75 | 01-09-12 |
Director/Board Member | 61 | 01/11 | |
Gregory Waller
BRD | Director/Board Member | 74 | 03-08-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,06% | 219 mld. | |
+6,94% | 183 mld. | |
+13,54% | 136 mld. | |
+25,50% | 107 mld. | |
-4,30% | 63,07 mld. | |
+7,76% | 52,55 mld. | |
+11,59% | 51,28 mld. | |
+1,14% | 41,21 mld. | |
+3,21% | 36,43 mld. |